Dubourg J, Ueki K, Grouin JM, Fouqueray P, et al. Efficacy And Safety Of Imeglimin In Japanese Patients With Type 2 Diabetes Mellitus: A 24-Week, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Phase 2b Trial. Diabetes Obes Metab 2020 Dec 4. doi: 10.1111/dom.14285.
PMID: 33275318